Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05431270 |
Title | Dose Escalation/Expansion Study of PT199 (an Anti-CD73 mAb) Administered Alone and in Combination With a PD-1 Inhibitor |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Phanes Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Carolina BioOncology Institute | RECRUITING | Huntersville | North Carolina | 28078 | United States | Details |
Sarah Cannon Research Institute University of Oklahoma | RECRUITING | Oklahoma City | Oklahoma | 73104 | United States | Details |
SCRI Oncology Partners | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
The University of Texas MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
Tranquility Research | RECRUITING | Webster | Texas | 77598 | United States | Details |
NEXT Oncology | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |